Kento Takenaka

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Topics

Angiotensin Converting Enzyme

Artificial Intelligence

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

This page only lists publications with an associated author ORCID identifier.

Publications

Kento Takenaka, Yoshio Kitazume, Ami Kawamoto, Toshimitsu Fujii, Yumi Udagawa, Ryosuke Wanatabe, Hiromichi Shimizu, Shuji Hibiya, Masakazu Nagahori, Kazuo Ohtsuka, Hiroyuki Sato, Akihiro Hirakawa, Mamoru Watanabe, Ryuichi Okamoto
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease. The American journal of gastroenterology (2022)
Kento Takenaka, Yoshio Kitazume, Ami Kawamoto, Toshimitsu Fujii, Yumi Udagawa, Ryosuke Wanatabe, Hiromichi Shimizu, Shuji Hibiya, Masakazu Nagahori, Kazuo Ohtsuka, Hiroyuki Sato, Akihiro Hirakawa, Mamoru Watanabe, Ryuichi Okamoto
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease. The American journal of gastroenterology (2022)
Ami Kawamoto, Kento Takenaka, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
Systematic review of artificial intelligence-based image diagnosis for inflammatory bowel disease. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 34 (7) (2022)
Kento Takenaka, Ami Kawamoto, Shuji Hibiya, Kohei Suzuki, Toshimitsu Fujii, Maiko Motobayashi, Hiromichi Shimizu, Masakazu Nagahori, Eiko Saito, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease. Alimentary pharmacology & therapeutics 54 (8) (2021)
Miyuki Kaneshiro, Kento Takenaka, Kohei Suzuki, Toshimitsu Fujii, Shuji Hibiya, Ami Kawamoto, Maiko Motobayashi, Hiromichi Shimizu, Masakazu Nagahori, Eiko Saito, Ryuichi Okamoto, Kazuo Ohtsuka, Mamoru Watanabe
Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission. Alimentary pharmacology & therapeutics 53 (8) (2021)
Kento Takenaka, Ami Kawamoto, Kazuo Ohtsuka
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' reply. Alimentary pharmacology & therapeutics 54 (8) (2021)
Kento Takenaka, Yoshio Kitazume, Toshimitsu Fujii, Kiichiro Tsuchiya, Mamoru Watanabe, Kazuo Ohtsuka
Objective evaluation for treat to target in Crohn's disease. Journal of gastroenterology 55 (6) (2020)
Kento Takenaka, Maiko Kimura, Kazuo Ohtsuka
Colonic strictures mimicking Crohn's disease. Gut 70 (2) (2019)